Hannah Kleine‐Weber - Researcher Profile

Publications

2 shown

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann , Hannah Kleine‐Weber , Simon Schroeder +10 more

The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency. Cell entry...

2020 Cell 20901 citations

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Markus Hoffmann , Hannah Kleine‐Weber , Nadine Krüger +3 more

Abstract The emergence of a novel, highly pathogenic coronavirus, 2019-nCoV, in China, and its rapid national and international spread pose a global health emergency. Coronaviru...

2020 bioRxiv (Cold Spring Harbor Laboratory) 754 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 21,655
Institution: German Primate Center

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.